The Enterprise Value as of November 2024 (TTM) for IGM Biosciences, Inc. (IGMS) is 922.10M

According to IGM Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 922.10M. This represents a change of 116.91% compared to the average of 425.11M of the last 4 quarters.

IGM Biosciences, Inc. (IGMS) Historical Enterprise Value (quarterly & annually)

How has IGMS Enterprise Value performed in the past?

The mean historical Enterprise Value of IGM Biosciences, Inc. over the last ten years is 671.16M. The current 922.10M Enterprise Value has changed 13.64% with respect to the historical average. Over the past ten years (40 quarters), IGMS's Enterprise Value was at its highest in in the June 2021 quarter at 2.54B. The Enterprise Value was at its lowest in in the September 2019 quarter at -108359885.00.

IGM Biosciences, Inc. (IGMS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of IGM Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

IGM Biosciences, Inc. (IGMS) Average Enterprise Value

How has IGMS Enterprise Value performed in the past?

The current Enterprise Value of IGM Biosciences, Inc. (IGMS) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

IGM Biosciences, Inc. (IGMS) Enterprise Value vs. Peers

How is IGMS’s Enterprise Value compared to its peers?

IGM Biosciences, Inc.’s Enterprise Value is less than Avidity Biosciences, Inc. (4.73B), less than Cerevel Therapeutics Holdings, Inc. (8.24B), greater than Cullinan Oncology, Inc. (813.60M), greater than Mineralys Therapeutics, Inc. (603.45M), greater than Monte Rosa Therapeutics, Inc. (481.73M), greater than Design Therapeutics, Inc. (257.66M), greater than Werewolf Therapeutics, Inc. (2.33M), greater than Ikena Oncology, Inc. (47.35M), greater than Stoke Therapeutics, Inc. (494.86M), less than Gracell Biotechnologies Inc. (5.47B), greater than Theseus Pharmaceuticals, Inc. (138.26M), greater than Erasca, Inc. (689.13M), greater than TCR2 Therapeutics Inc. (49.64M), less than Revolution Medicines, Inc. (9.13B), greater than Black Diamond Therapeutics, Inc. (159.64M), greater than Atreca, Inc. (-8620212.00), greater than Passage Bio, Inc. (38.99M),

Build a custom stock screener for IGM Biosciences, Inc. (IGMS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IGM Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

IGM Biosciences, Inc. (IGMS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like IGM Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.